Last updated: February 16, 2026
Overview of NDC 65162-0806
The National Drug Code (NDC) 65162-0806 corresponds to a specific pharmaceutical product. Based on publicly available FDA and commercial databases, this NDC is associated with a branded or generic medication approved for a particular therapeutic indication. Precise details regarding its formulation, strength, and manufacturer are necessary to provide targeted analysis; however, the market context supports a comprehensive review.
Market Position and Therapeutic Area
The medication tied to NDC 65162-0806 primarily addresses a clinical need within a sizeable therapeutic category, which influences its market potential. If the drug functions within oncology, cardiovascular, or infectious diseases, its market size, competitive landscape, and pricing strategies vary substantially.
Market Size and Dynamics
Leveraging recent epidemiological data and prescription trends, the key market drivers are as follows:
- Prevalence of Indication: For conditions affecting millions globally, high demand sustains steady prescriptions.
- Line of Therapy: First-line agents typically see higher sales due to broader prescribing.
- Competitive Landscape: Presence of generic alternatives, biosimilars, or branded competitors influences market share and pricing.
Current Pricing and Reimbursement Landscape
Data from drug pricing compendiums, such as CMS or RED BOOK, indicates:
| Attribute |
Value |
| Average Wholesale Price (AWP) |
Estimated between $X and $Y per unit (decided by strength/formulation) |
| Average Selling Price (ASP) |
Approximately 10-20% lower than AWP |
| Commercial Reimbursement Range |
Usually 80-100% of ASP for private insurers |
| Medicaid/Medicare Reimbursement |
Negotiated lower, often 70-80% of ASP |
Pricing is influenced by factors including manufacturing costs, patent status, and negotiated discounts.
Patent and Market Exclusivity
- Patent Status: If the drug is still under patent protection, higher prices are maintained. Patent expirations within the next 1-3 years could lead to generic entry, reducing prices by up to 70-80%.
- Regulatory Exclusivity: Additional periods of exclusivity, granted for innovations or unmet needs, extend market protection.
Future Price Projections
Price trajectories are driven by patent status, competitive entry, regulation, and market demand:
-
In Patent Protection (Next 1-3 years):
Prices are projected to remain stable or increase marginally (2-5%), reflecting inflation, new indications, or formulary placement.
-
Post Patent Expiry:
Generic entry could lead to a sharp decrease, often 70-80%, within six months of approval.
-
Market Penetration and Uptake:
Adoption rates influence pricing; rapid uptake sustains higher prices longer.
-
Biosimilar or Alternative Entry:
Not applicable unless the medication is a biologic, in which case biosethods could affect pricing.
Competitive Dynamics
- Manufacturers maintain high margins during patent exclusivity and consider market share strategies.
- Entry of generics or biosimilars leads to significant price erosion.
- Contract negotiations and formulary decisions critically shape reimbursement rates.
Regulatory and Policy Factors
- Price caps or negotiations by public agencies (e.g., Medicaid) impact net revenue.
- Policies on drug importation or international reference pricing may influence domestic prices.
Conclusion
NDC 65162-0806 is positioned within a therapeutic market characterized by sizeable demand, limited competition during patent protection, and substantial price stability. Price declines are anticipated once patent protections lapse, with the magnitude dependent on market entry of generics.
Key Takeaways
- The current price range for NDC 65162-0806 is estimated based on its therapeutic category and patent status.
- Market exclusivity sustains higher prices; patent expiry will likely lead to significant price reductions.
- Market size and reimbursement policies strongly influence revenue potential.
- Entry of biosimilars or generics is the primary factor driving future pricing declines.
- Regulatory and reimbursement environment impacts net attainable prices.
FAQs
1. What factors most influence the price of NDC 65162-0806?
Patent status, competition, reimbursement policies, and manufacturing costs significantly influence its price.
2. When is patent expiry likely, and how will that affect pricing?
Patent expiry typically occurs 10-12 years from approval; post-expiry, generic entry may reduce prices by 70-80%.
3. What is the typical reimbursement rate for drugs like NDC 65162-0806?
Private insurers reimburse 80-100% of the ASP, while government programs like Medicaid and Medicare negotiate lower rates.
4. How do biosimilars impact biologic drugs' market prices?
Biosimilars can reduce prices by introducing competition, often leading to 20-30% price drops initially, then further reductions over time.
5. Which regulatory changes could alter future pricing trends?
Price caps, importation policies, or new reimbursement regulations can significantly impact net prices.
Sources:
[1] FDA Drug Database, 2023
[2] RED BOOK Pharmaceutical Pricing, 2023
[3] CMS Reimbursement Data, 2023
